Stage Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Stage Biopharmaceutical stocks.

Stage Biopharmaceutical Stocks Recent News

Date Stock Title
May 16 ACXP Acurx Pharmaceuticals Inc (ACXP) Q1 2024 Earnings Call Transcript Highlights: Key Financial and ...
May 16 ACXP Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
May 15 ASND FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
May 15 ACXP Acurx Pharmaceuticals, Inc. (ACXP) Q1 2024 Earnings Call Transcript
May 15 ASND FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
May 15 ABVC Promising Combination Therapy for Triple Negative Breast Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, Potential Income of $13.75M and Royalties of up to $12.50M
May 15 ACXP Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection
May 15 ACXP Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update
May 15 ACXP Acurx Pharmaceuticals GAAP EPS of -$0.28 misses by $0.04
May 15 CLRB Q1 2024 Cellectar Biosciences Inc Earnings Call
May 15 CLRB Cellectar Biosciences Inc (CLRB) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 14 ASND US Equity Markets Close Higher Tuesday as Producer Prices Rise
May 14 ASND Ascendis Pharma says FDA has delayed TransCon PTH review
May 14 ASND UPDATE 1-FDA extends review of Ascendis Pharma's hormone disorder therapy
May 14 CADL Candel Therapeutics GAAP EPS of -$0.28
May 14 ASND Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism
May 14 CLRB Cellectar Biosciences, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 14 CLRB Cellectar Biosciences, Inc. (CLRB) Q1 2024 Earnings Call Transcript
May 14 AVTE Aerovate Therapeutics reports Q1 GAAP EPS of -$0.83
May 14 CADL Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Stage Biopharmaceutical

Browse All Tags